Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
 
(5 intermediate revisions by 2 users not shown)
Line 6: Line 6:
  
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 +
__TOC__
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
 
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
Line 16: Line 17:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
!
 
−
!
 
−
!
 
−
!
 
−
!
 
 
|-
 
|-
−
|CHAPTER 2 (SOFT TISSUE TUMOURS)
 
 
|
 
|
−
----
+
==== CHAPTER 2 (SOFT TISSUE TUMOURS) ====
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
 
|
 
|
 
----
 
----
Line 54: Line 41:
 
|[[STBT5:Lipoma|Lipoma]]
 
|[[STBT5:Lipoma|Lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 70: Line 52:
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|[[STBT5:Lipomatosis|Lipomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 86: Line 63:
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 102: Line 74:
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 118: Line 85:
 
|[[STBT5:Angiolipoma_|Angiolipoma]]
 
|[[STBT5:Angiolipoma_|Angiolipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 134: Line 96:
 
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 150: Line 107:
 
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 166: Line 118:
 
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 182: Line 129:
 
|[[STBT5:Hibernoma|Hibernoma]]
 
|[[STBT5:Hibernoma|Hibernoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 198: Line 140:
 
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 214: Line 151:
 
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 235: Line 167:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 244: Line 182:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
+
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 254: Line 192:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 267: Line 203:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 276: Line 215:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
+
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 
|Disease
 
|Disease
 
|
 
|
Line 286: Line 225:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 299: Line 236:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 308: Line 248:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
+
|[[STBT5:Elastofibroma|Elastofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 315: Line 255:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 324: Line 270:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
+
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 
|Disease
 
|Disease
 
|
 
|
Line 334: Line 280:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 347: Line 291:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 356: Line 303:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Elastofibroma|Elastofibroma]]
+
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 
|Disease
 
|Disease
 
|
 
|
Line 366: Line 313:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 379: Line 324:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 388: Line 336:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
+
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 395: Line 343:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 404: Line 358:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
+
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 414: Line 368:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 427: Line 379:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 436: Line 391:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
+
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 446: Line 401:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 459: Line 412:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 468: Line 424:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
+
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 475: Line 431:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 484: Line 446:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
+
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 494: Line 456:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 507: Line 467:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 516: Line 479:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
+
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 +
|Shashi Shetty and Reba Daniel (resident)
 +
|2/21/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
 +
|Template added 2/21/2024
 +
|-
 +
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 529: Line 500:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 539: Line 510:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 548: Line 523:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
+
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 558: Line 533:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 571: Line 544:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 580: Line 556:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
+
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 590: Line 566:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 595: Line 574:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 609: Line 588:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 619: Line 598:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 628: Line 611:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
+
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 638: Line 621:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 651: Line 632:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 660: Line 644:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
+
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 670: Line 654:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 683: Line 665:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 692: Line 677:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
+
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 
|Disease
 
|Disease
−
|Shashi Shetty and Reba Daniel (resident)
 
−
|2/21/2024
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|Template added 2/21/2024
 
 
|
 
|
 
|
 
|
Line 708: Line 688:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 715: Line 695:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 724: Line 710:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
+
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 731: Line 717:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 740: Line 732:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
+
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 750: Line 742:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 763: Line 753:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 772: Line 765:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
+
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 779: Line 772:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 788: Line 787:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
+
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 798: Line 797:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 811: Line 808:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 820: Line 820:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
+
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 830: Line 830:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Leiomyoma|Leiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 843: Line 841:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 852: Line 853:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
+
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 859: Line 860:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 868: Line 875:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
+
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 878: Line 885:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 891: Line 896:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 900: Line 908:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
+
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 910: Line 918:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 923: Line 929:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 932: Line 941:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
+
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 939: Line 948:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 948: Line 963:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
+
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 958: Line 973:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 971: Line 984:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 980: Line 996:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
+
|[[STBT5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 990: Line 1,006:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,003: Line 1,017:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,012: Line 1,029:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
+
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,019: Line 1,036:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,028: Line 1,051:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
+
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,038: Line 1,061:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,051: Line 1,072:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,060: Line 1,084:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
+
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,070: Line 1,094:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,083: Line 1,105:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,092: Line 1,117:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,102: Line 1,127:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,115: Line 1,138:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,124: Line 1,150:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
+
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,134: Line 1,160:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,147: Line 1,171:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,156: Line 1,183:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Glomus_tumour|Glomus tumour]]
+
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 1,172: Line 1,194:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
+
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,182: Line 1,204:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 +
|Disease
 +
|James Solomon, MD, PhD
 +
|2/20/2022
 
|
 
|
 +
|PENDING
 +
|
 +
|Alanna Church
 
|
 
|
 
|
 
|
−
|
 
−
|
 
 
|-
 
|-
−
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
+
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,198: Line 1,226:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Leiomyoma|Leiomyoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,211: Line 1,237:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,220: Line 1,249:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
+
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,230: Line 1,259:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,243: Line 1,270:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,252: Line 1,282:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
+
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,259: Line 1,289:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:PEComa|PEComa]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,268: Line 1,304:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
+
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,278: Line 1,314:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,283: Line 1,322:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
==== CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
+
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 +
|Sadeem Qdaisat
 +
|10/1/23
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Working with Eric McGinnis
 
|
 
|
−
|
+
|2021 template added
−
|
+
|-
 +
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,316: Line 1,369:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
+
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 +
|Ganesh Pandurang, MD
 +
|2/28/24
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
 
|
 
|
−
|
+
|-
 +
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,332: Line 1,391:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 +
==== CHAPTER 4 (BONE TUMOURS) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,355: Line 1,422:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,364: Line 1,434:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
+
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,374: Line 1,444:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Enchondroma|Enchondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,387: Line 1,455:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteochondroma|Osteochondroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,396: Line 1,467:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
+
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,406: Line 1,477:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Schwannoma|Schwannoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,419: Line 1,488:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,428: Line 1,500:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Neurofibroma|Neurofibroma]]
+
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,438: Line 1,510:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,443: Line 1,518:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Perineurioma|Perineurioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,456: Line 1,531:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,467: Line 1,543:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,476: Line 1,555:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
+
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,486: Line 1,565:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,499: Line 1,576:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,508: Line 1,588:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
+
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,518: Line 1,598:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteoma|Osteoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,523: Line 1,606:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,536: Line 1,619:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,547: Line 1,631:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,556: Line 1,643:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
+
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,566: Line 1,653:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,579: Line 1,664:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,588: Line 1,676:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
+
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,598: Line 1,686:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,603: Line 1,694:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,616: Line 1,707:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,627: Line 1,719:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,636: Line 1,731:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
+
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,646: Line 1,741:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,659: Line 1,752:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,668: Line 1,764:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
+
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,678: Line 1,774:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,683: Line 1,782:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,696: Line 1,795:
 
|
 
|
 
|
 
|
 +
|
 +
|-
 +
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,707: Line 1,807:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,716: Line 1,819:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
+
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,726: Line 1,829:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,739: Line 1,840:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,748: Line 1,852:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
+
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
|Disease
 
|Disease
−
|James Solomon, MD, PhD
 
−
|2/20/2022
 
 
|
 
|
−
|PENDING
 
−
|
 
−
|Alanna Church
 
 
|
 
|
 
|
 
|
Line 1,764: Line 1,863:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
+
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,771: Line 1,870:
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,780: Line 1,885:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
+
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,790: Line 1,895:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,803: Line 1,906:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,812: Line 1,918:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
+
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,822: Line 1,928:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,835: Line 1,939:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Bone_metastases|Bone metastases]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,844: Line 1,951:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
+
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,854: Line 1,961:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,867: Line 1,972:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,876: Line 1,984:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:PEComa|PEComa]]
+
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,886: Line 1,994:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,891: Line 2,002:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 
|
 
|
 +
==== CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE) ====
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
+
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,918: Line 2,037:
 
|
 
|
 
|
 
|
−
|
+
|-
−
|
+
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
−
|
+
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|-
+
|N/A
−
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
+
|N/A
−
|
+
|N/A
−
----
+
|N/A
−
|
+
|N/A
−
----
+
|N/A
−
|
+
|-
−
----
+
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
−
|
+
|Disease
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|-
 
−
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
−
|Disease
 
−
|Sadeem Qdaisat
 
−
|10/1/23
 
−
|
 
−
|PENDING
 
−
|
 
−
|Working with Eric McGinnis
 
−
|
 
−
|2021 template added
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CHAPTER 4 (BONE TUMOURS)
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|-
 
−
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Enchondroma|Enchondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondroma|Osteochondroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoma|Osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Bone_metastases|Bone metastases]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|
 
−
----
 
−
|-
 
−
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 2,992: Line 2,062:
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 3,008: Line 2,073:
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|-
 
|-
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|
Line 3,040: Line 2,095:
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|[[STBT5:Werner_syndrome|Werner syndrome]]
 
|Disease
 
|Disease
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 
|
 
|

Latest revision as of 13:47, 10 September 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease
Elastofibroma Disease
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Solitary fibrous tumour Disease Shashi Shetty and Reba Daniel (resident) 2/21/2024 PENDING Katherine Geiersbach Template added 2/21/2024
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease
Infantile fibrosarcoma Disease
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Giant cell tumour of soft tissue Disease
Synovial haemangioma Disease
Intramuscular angioma Disease
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease
Haemosiderotic fibrolipomatous tumour Disease
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Clear cell sarcoma of soft tissue Disease
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat 10/1/23 PENDING Working with Eric McGinnis 2021 template added
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease Ganesh Pandurang, MD 2/28/24 PENDING Katherine Geiersbach
Sarcoma with BCOR genetic alterations Disease

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Osteosarcoma Disease
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease
Osteofibrous dysplasia Disease
Adamantinoma of long bones Disease
Simple bone cyst Disease
Fibrocartilaginous mesenchymoma Disease
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Langerhans cell histiocytosis Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=15409"